Surgery Medical News about Quebec breast cancer screening program

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Quebec breast cancer screening program: A study of the perceptions of physicians in Laval, Que
Canadian Family Physician, 06/15/09

Nguyen M-N et al. - This study suggests that medical practices, tools, and strategies for breast cancer screening in Laval are functional but need improvement.

The Quebec breast cancer screening program (QBCSP) was introduced in 1998 to facilitate early breast cancer screening using mammography. The program aims to reach and maintain a 70% participation rate, the estimated rate needed to improve mortality. In Laval, Que, however, the participation rate is between 42% and 46%.
This study used in-depth interviews to explore physicians perspectives on the QBCSP. Because screening and referral centres offered different services and other jurisdictions were often perceived to be more efficient, many physicians preferred to refer their patients to referral centres or to adjacent jurisdictions; this contributes to delays in appointment scheduling and prevents quality assurance and proper assessment of the QBCSP.
Participants also disagreed about when mammography and clinical breast examination should be started and about whether to teach breast self-examination; they generally did not follow guide-lines on these issues.

<< Previous
Practical recommendations for the early use of m-TOR inhibitors...

Next >>
The number of lymph nodes involved with metastatic disease does...